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Background: Family history of acute myocardial infarction (AMI) and recently discovered alleles are highly associated with AMI. However, current 
predictive algorithms such as the Framingham Risk Score (FRS) ignore these factors when assessing 10 year risk of AMI.
Methods: Subjects in the study were participants in the Marshfield Clinic Personalized Medicine Research Project (PMRP) between the ages of 
40 to 80 at enrollment. ‘Cases’ were those who had an initial non-fatal (AMI) or had been hospitalized for unstable angina (USA) during 5 years 
of follow-up. There were 381 total cases (164 with an initial AMI and 217 hospitalized with USA). ‘Controls’ (n=1058) were selected from the 
population. Genotyping was performed previously for 51 alleles associated with a number of different diseases. Associations with AMI and USA were 
tested using chi-squared analysis and corrections for multiple comparisons were made using a false discovery rate of 30%. Sex stratification was 
performed due to known sex differences with many of the tested alleles.
Results: Six alleles were significant at the level of 0.05 uncorrected p-value (rs486907, rs231775, rs213950, rs2383206, rs1800872, and 
rs429358). Three alleles were significant after adjustment with one additional allele significant only for the female sex after adjustment. Odds 
ratios ranged from 2.3 for rs1800872 homozygous AA, to 1.4 for homozygous AA at rs213950. Carrying at least 2 high risk genotypes increased the 
chances of incurring an AMI OR 1.85 for the population with 40 % of the individuals who had an AMI carrying at least 2 risk alleles. Stratification 
of each risk allele by sex improved the risk prediction increasing the OR of AMI to 2.09 with 41% of the female cases carrying at least 2 high risk 
alleles.
Conclusion: This study demonstrates the feasibility of identifying individuals who may be at increased risk of AMI using a very limited set of genetic 
markers and may represent the one of the first steps for incorporating genetic markers into short term risk calculations. In addition this study 
demonstrates the need to stratify genetic data by sex, as disease susceptibility may be influenced by different alleles for males and females.
